BID and fatty liver disease: Notably, ABX treatment abrogated the difference between the WT and bid−/− mice in the expression of these genes (Figure 6E) and hepatic steatosis, suggesting a mechanistic connection among BID, GM, and lipid metabolism under the overfed condition.